370 related articles for article (PubMed ID: 14708020)
1. Crystal structures of drugs: advances in determination, prediction and engineering.
Datta S; Grant DJ
Nat Rev Drug Discov; 2004 Jan; 3(1):42-57. PubMed ID: 14708020
[No Abstract] [Full Text] [Related]
2. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
LaPorte TL; Wang C
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
[TBL] [Abstract][Full Text] [Related]
3. Biocatalysis: synthesis of chiral intermediates for drugs.
Patel RN
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
[TBL] [Abstract][Full Text] [Related]
4. Guiding molecules towards drug-likeness.
Egan WJ; Walters WP; Murcko MA
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312
[TBL] [Abstract][Full Text] [Related]
5. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of hydration in drug design.
Mancera RL
Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.
Krajewski WW; Collins R; Holmberg-Schiavone L; Jones TA; Karlberg T; Mowbray SL
J Mol Biol; 2008 Jan; 375(1):217-28. PubMed ID: 18005987
[TBL] [Abstract][Full Text] [Related]
8. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
Reutzel-Edens SM
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
[TBL] [Abstract][Full Text] [Related]
9. Using X-ray crystallography in drug discovery.
Rowland RS
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pH-dependent aqueous solubility of druglike molecules.
Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
[TBL] [Abstract][Full Text] [Related]
11. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
[TBL] [Abstract][Full Text] [Related]
12. Form finds function.
Allen KN
Nat Chem Biol; 2007 Aug; 3(8):452-3. PubMed ID: 17637773
[No Abstract] [Full Text] [Related]
13. Are pharmaceutics really going supercritical?
Pasquali I; Bettini R
Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957
[TBL] [Abstract][Full Text] [Related]
14. March of the synthesis machines.
Sanderson K
Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
[No Abstract] [Full Text] [Related]
15. [The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations].
Antal I
Acta Pharm Hung; 2006; 76(3):149-54. PubMed ID: 17094663
[TBL] [Abstract][Full Text] [Related]
16. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
17. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
Almarsson O; Zaworotko MJ
Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589
[TBL] [Abstract][Full Text] [Related]
18. Physics-based methods for studying protein-ligand interactions.
Huang N; Jacobson MP
Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
[TBL] [Abstract][Full Text] [Related]
19. Application of statistical 'design of experiments' methods in drug discovery.
Tye H
Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
[TBL] [Abstract][Full Text] [Related]
20. Identification of drugs that interact with herbs in drug development.
Zhou SF; Zhou ZW; Li CG; Chen X; Yu X; Xue CC; Herington A
Drug Discov Today; 2007 Aug; 12(15-16):664-73. PubMed ID: 17706549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
